JD Health International Inc. (HKG:6618)

JD Health International Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	20,446	31,785	22,629	15,037	18,718	17,252
Short-Term Investments	13,726	15,864	18,169	16,799	27,951	23,637
Trading Asset Securities	13,244	501.37	10,438	9,385	1,003	1,101
Cash & Short-Term Investments	47,416	48,151	51,236	41,221	47,672	41,990
Cash Growth	-3.83%	-6.02%	24.29%	-13.53%	13.53%	4.18%
Accounts Receivable	547.36	742.86	857.92	706.76	1,301	405.68
Other Receivables	-	365.54	289.04	265.35	686.59	53.75
Receivables	547.36	1,108	1,147	972.1	1,988	459.43
Inventory	7,384	6,858	5,843	5,085	5,996	3,041
Prepaid Expenses	-	33.2	20.72	16.35	15.79	14.03
Restricted Cash	6.84	7.74	32.66	15.38	33	25.35
Other Current Assets	2,753	190.69	181.73	540.23	742.43	175.35
Total Current Assets	58,107	56,349	58,460	47,850	56,447	45,705
Property, Plant & Equipment	1,497	1,230	795.99	288	251.91	260.78
Long-Term Investments	21,101	21,644	9,584	13,197	1,523	1,031
Other Intangible Assets	1,820	1,933	2,095	2,182	2,268	25.39
Long-Term Deferred Tax Assets	233.53	399.23	312.93	299.83	208.47	95.86
Other Long-Term Assets	1,413	31.43	26.89	471.77	578.98	883.8
Total Assets	84,171	81,587	71,275	64,288	61,277	48,002

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	14,450	16,587	12,484	11,340	11,143	5,710
Accrued Expenses	5,709	694.39	391.88	305.78	1,204	180.82
Current Portion of Leases	265.68	206.64	109.67	95.32	70.65	67.55
Current Income Taxes Payable	631.53	598.27	207.1	337.54	380.19	118.81
Current Unearned Revenue	584.17	552.31	537.92	405.6	1,375	395.41
Other Current Liabilities	-	2,103	1,791	2,100	2,184	1,532
Total Current Liabilities	21,640	20,741	15,521	14,585	16,356	8,005
Long-Term Leases	609.17	429.38	148.72	119.43	128.76	133.72
Long-Term Deferred Tax Liabilities	466.17	342.61	364.41	213.61	7.82	8.89
Total Liabilities	22,715	21,513	16,034	14,918	16,493	8,148

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	-	61,423	59,977	58,551	57,063	56,242
Retained Earnings	-4,534	-7,971	-13,224	-17,336	-19,382	-19,715
Treasury Stock	-757.7	-34.54	-60.73	-92.57	-34.3	-50.64
Comprehensive Income & Other	66,748	6,654	8,539	8,233	7,134	3,377
Total Common Equity	61,456	60,072	55,231	49,356	44,780	39,853
Minority Interest	-	1.39	9.68	14.51	4.31	1.19
Shareholders' Equity	61,456	60,073	55,241	49,370	44,785	39,855
Total Liabilities & Equity	84,171	81,587	71,275	64,288	61,277	48,002

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	874.85	636.02	258.39	214.75	199.41	201.27
Net Cash (Debt)	46,541	47,514	50,977	41,007	47,473	41,789
Net Cash Growth	-4.78%	-6.79%	24.32%	-13.62%	13.60%	3.92%
Net Cash Per Share	14.53	14.87	16.13	12.96	15.10	13.50
Filing Date Shares Outstanding	3,178	3,167	3,146	3,127	3,106	3,098
Total Common Shares Outstanding	3,178	3,167	3,146	3,127	3,106	3,098
Working Capital	36,467	35,607	42,939	33,265	40,091	37,700
Book Value Per Share	19.34	18.97	17.56	15.78	14.42	12.86
Tangible Book Value	59,636	58,139	53,137	47,174	42,512	39,828
Tangible Book Value Per Share	18.77	18.36	16.89	15.08	13.69	12.86

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 19, 2026

Data Sources Report a data error